Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial

Completed · Phase 3

Conditions studied: Age Related Macular Degeneration

In brief

The purpose of the study is to evaluate the relative efficacy and safety of treatment of neovascular AMD with Lucentis on a fixed schedule, Avastin on a fixed schedule, Lucentis on a variable schedule, and Avastin on a variable schedule. A five year follow-up visit is being conducted in 2014 to gather information on long term outcomes.

Key facts

Study ID
NCT00593450
Run by
University of Pennsylvania
People needed
1208
Starts
2008-02-01
Expected to finish
2015-04-01
Last updated by the study team
2017-08-21

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.